The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of 12 ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

This was the stock's second consecutive day of gains.

Rashad Burgess is the Executive Director for HIV Community Operations at Gilead Sciences. He spoke with Kayla Thompson about importance of screening, health, and more!

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

President Donald Trump said in a letter Thursday that he will raise taxes on many imported goods from Canada to 35%, ...

Trump administration funding cuts and dismantling of USAID force a shift from HIV elimination back to treatment.

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...